Advances in exogenous docosahexaenoic acid‐containing phospholipids: Sources, positional isomerism, biological activities, and advantages
Tóm tắt
In recent years, docosahexaenoic acid‐containing phospholipids (DHA‐PLs) have attracted much attention because of theirs unique health benefits. Compared with other forms of docosahexaenoic acid (DHA), DHA‐PLs possess superior biological effects (e.g., anticancer, lipid metabolism regulation, visual development, and brain and nervous system biochemical reactions), more intricate metabolism mechanisms, and a stronger attraction to consumer. The production of DHA‐PLs is hampered by several challenges associated with the limited content of DHA‐PLs in natural sources, incomplete utilization of by‐products, few microorganisms for DHA‐PLs production, high cost, and complex process of artificial preparation of DHA‐PLs. In this article, the sources, biological activities, and commercial applications of DHA‐PLs were summarized, with intensive discussions on advantages of DHA‐PLs over DHA, isomerism of DHA in phospholipids (PLs), and brain health. The excellent biological characteristics of DHA‐PLs are primarily concerned with DHA and PLs. The metabolic fate of different DHA‐PLs varies from the position of DHA in PLs to polar groups in DHA‐PLs. Overall, well understanding of DHA‐PLs about their sources and characteristics is critical to accelerate the production of DHA‐PLs, economically enhance the value of DHA‐PLs, and improve the applicability of DHA‐PLs and the acceptance of consumers.
Từ khóa
Tài liệu tham khảo
Bartel B. B. &Daniels R. S.(2015).U.S. Patent No. 20150250806 A1. Washington DC: U.S. Patent and Trademark Office.
Bartke N. &Wobbes B.(2016).U.S. Patent No. 2016367511A1. Washington DC: U.S. Patent and Trademark Office.
Bruheim I. &Grinnari M.(2008).U.S. Patent No. 2008058286A1. Washington DC: U.S. Patent and Trademark Office.
Bruheim I. Hallaraker H. Banno S. &Griinari M.(2008).U.S. Patent No. 2008070870A1. Washington DC: U.S. Patent and Trademark Office.
Bunea R., 2004, Evaluation of the effects of neptune krill oil on the clinical course of hyperlipidemia, Alternative Medicine Review, 9, 420
Daniels R. S. &Bartel B. B.(2016).U.S. Patent No. 20160158257A1. Washington DC: U.S. Patent and Trademark Office.
Hallaraker H. Remmereit J. &Berger A.(2019).U.S. PatentNo. 2019015433A1.Washington DC:U.S. Patent and Trademark Office.
Hosokawa M., 2005, Preparation of polyunsaturated phospholipids and their functional properties, Handbook of Industrial Biocatalysis, 2005, 268
Kaspar I. Krüger V. Röthlein D. Schmitt J. &Wolf M.(2015).U.S. Patent No. 2015018320A1. Washington DC: U.S. Patent and Trademark Office.
Lemaitre‐Delaunay D., 1999, Blood compartmental metabolism of docosahexaenoic acid (DHA) in humans after ingestion of a single dose of [C‐13]DHA in phosphatidylcholine, Journal of Lipid Research, 40, 1867, 10.1016/S0022-2275(20)34903-8
Li X. P., 2019, Extraction and purification of eicosapentaenoic acid and docosahexaenoic acid from microalgae: A critical review, Algal Research‐Biomass Biofuels and Bioproducts, 43, 101619
Matsuda T., 1994, Characterization of interactions between transducin alpha/beta‐gamma‐subunits and lipid‐membranes, Journal of Biological Chemistry, 269, 30358, 10.1016/S0021-9258(18)43821-5
Minatelli J. A. Hill W. S. &Moerck R. E.(2013).U.S. No. Patent 8557275B2. Washington DC: U.S. Patent and Trademark Office.
Murakami K., 2010, Formation of the 42‐mer amyloid β radical and the therapeutic role of superoxide dismutase in Alzheimer's disease, Journal of Amino Acids, 2011, 654207
Petrs‐Silva H., 2014, Advances in gene therapy technologies to treat retinitis pigmentosa, Clinical Ophthalmology, 8, 127
Pieroni G. &Coste T.(2010).U.S. Patents No. 7842679B2. Washington DC: U.S. Patent and Trademark Office.
Qin M. A., 2008, Anti‐tumor activities and immune regulation of docosahexaenoic acid‐phosphatidylcholine liposomes in mice bearing S(180), Journal of China Pharmaceutical University, 39, 159
Regev D. Z. Chudnow R. Richter Y. &Soria A. O. G.(2017).U.S. Patent 20170360812 A1. Washington DC: U.S. Patent and Trademark Office.
Sampalis F.(2017).U.S. Patent 20170216322A1. Washington DC: U.S. Patent and Trademark Office.
Sampalis F., 2003, Evaluation of the effects of Neptune Krill Oil on the management of premenstrual syndrome and dysmenorrhea, Alternative Medicine Review, 8, 171
Scheltens P., 2016, Alzheimer's disease, Postgraduate Medical Journal, 388, 505
Widberg A. Laoz H. Ben‐Dror G. Berkov Y. Lifshitz Y. &Herzog Y.(2019).U.S. Patent No. 2019105336A1. Washington DC: U.S. Patent and Trademark Office.
Wu C., 2018, Systemic therapy for colon cancer, Surgical Oncology Clinics, 27, 235
Zhang Z. W., 2019, Effect of n‐3 polyunsaturated fatty acids on dopaminergic neurons in substantia nigra, brain inflammatory response and behavior in mice with Parkinson's disease, Tropical Journal of Pharmaceutical Research, 18, 767, 10.4314/tjpr.v18i4.13